Cart
sales@molnova.com
Takeda103A
CAS No. 865609-72-9
Takeda103A( Takeda-103-A | Takeda 103 A | Takeda-103A | CMPD103A | CMPD-103A )
Catalog No. M24868 CAS No. 865609-72-9
Takeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 10MG | 406 | In Stock |
|
| 25MG | 669 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1251 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTakeda103A
-
NoteResearch use only, not for human use.
-
Brief DescriptionTakeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
-
DescriptionTakeda103A is the GRK2-dependent bovine tubulin oxidation effective inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsTakeda-103-A | Takeda 103 A | Takeda-103A | CMPD103A | CMPD-103A
-
PathwayOthers
-
TargetGRK (GPCRK)
-
RecptorGRK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number865609-72-9
-
Formula Weight463.49
-
Molecular FormulaC24H23F2N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCCN1C(=NN=C1C2=NC=NC=C2)CNC3=CC=CC(=C3)C(=O)NCC4=C(C=CC=C4F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Waldschmidt HV, Homan KT, Cruz-Rodríguez O, et al. Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors. J Med Chem. 2016 Apr 28;59(8):3793-807. doi: 10.1021/acs.jmedchem.5b02000. Epub 2016 Apr 13. PubMed PMID: 27050625.
molnova catalog
related products
-
GRK6-IN-1
GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM, and has potential for study in multiple myeloma.
-
GRK5-IN-2
GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
-
1-(2,3-DIHYDRO-BENZO...
1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID targets GRK2.
